Supporting scale-up for early-phase AAV- and LVV-based gene and gene-modified cell therapy researchers and developers WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback